鹏华上证科创板综合ETF

Search documents
鹏华基金闫冬:全固态电池技术解决方案相继发布,新能源锂电板块催化不断
Zhong Guo Jing Ji Wang· 2025-07-28 01:32
Group 1 - The National Development and Reform Commission and the State Administration for Market Regulation are soliciting opinions on the draft amendment to the Price Law, which aims to improve the identification standards for low-price dumping and regulate market price order, addressing "involution" competition [1] - The "anti-involution" policy is expected to be a key driver for the long-term profit recovery in the new energy industry as it progresses [2] - The Penghua CSI Science and Technology Innovation Board New Energy ETF (588830) is the first ETF product in the market focusing on both the "Science and Technology Innovation Board" and "New Energy" sectors, tracking the CSI Science and Technology Innovation New Energy Index [1] Group 2 - In May, the domestic photovoltaic installed capacity surged to 92.92 GW, driven by the "531" rush installation node, marking a historical monthly record [2] - The supply side still faces capacity pressure, and the government has reiterated the need to address "involution" competition, which is expected to enhance supply-side expectations starting from the end of June [2] - The current state of profitability in the photovoltaic and lithium battery sectors is at a low point, with photovoltaic losses being particularly significant, indicating that "anti-involution" policies could be crucial for long-term profit recovery in the new energy sector [2] Group 3 - Penghua Fund is actively participating in the construction of the science and technology innovation market, aiming to build a product matrix called "Science and Technology China · Lighthouse Fund" [3] - The expansion of the "Science and Technology China · Lighthouse Fund" is rapid, with new products being launched in both fixed income and equity sectors, including the Penghua CSI AAA Technology Innovation Company Bond ETF and various thematic ETFs [3] - The introduction of sector-specific ETFs, such as those focused on biomedicine and chips, provides investors with robust tools to capture diverse investment opportunities in the science and technology innovation board [3]